In BTKi treatment, inhibition of BTK may downregulate Notch, disrupting vascular homeostasis, increasing vascular resistance, and accelerating the development of hypertension in patients undergoing BTKi therapy (Del Papa et al., 2019). This evidence concerns the gene BTK and hypertensive disorder.